Literature DB >> 10733568

Recruitment of a basal polyadenylation factor by the upstream sequence element of the human lamin B2 polyadenylation signal.

S Brackenridge1, N J Proudfoot.   

Abstract

We have investigated how the upstream sequence element (USE) of the lamin B2 poly(A) signal mediates efficient 3'-end formation. In vitro analysis demonstrates that this USE increases both the efficiency of 3'-end cleavage and the processivity of poly(A) addition. Cross-linking using selectively labeled synthetic RNAs confirms that cleavage stimulation factor interacts with the sequences downstream of the cleavage site, while electrophoresis mobility shift assays demonstrate that the USE directly stabilizes the binding of the cleavage and polyadenylation specificity factor to the poly(A) signal. Thus in common with other poly(A) signals, the lamin B2 USE directly enhances the binding of basal poly(A) factors. In addition, a novel 55-kDa protein binds to the USE and the core poly(A) signal and appears to inhibit cleavage. The binding activity of this factor appears to change during the cell cycle, being greatest in S phase, when the lamin B2 gene is transcribed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10733568      PMCID: PMC85481          DOI: 10.1128/MCB.20.8.2660-2669.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  59 in total

1.  Functional analysis of point mutations in the AAUAAA motif of the SV40 late polyadenylation signal.

Authors:  J Wilusz; S M Pettine; T Shenk
Journal:  Nucleic Acids Res       Date:  1989-05-25       Impact factor: 16.971

2.  Sequences upstream of AAUAAA influence poly(A) site selection in a complex transcription unit.

Authors:  J D DeZazzo; M J Imperiale
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

3.  Efficiency of utilization of the simian virus 40 late polyadenylation site: effects of upstream sequences.

Authors:  S Carswell; J C Alwine
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

4.  3' non-coding region sequences in eukaryotic messenger RNA.

Authors:  N J Proudfoot; G G Brownlee
Journal:  Nature       Date:  1976-09-16       Impact factor: 49.962

5.  Sequence elements upstream of the 3' cleavage site confer substrate strength to the adenovirus L1 and L3 polyadenylation sites.

Authors:  J Prescott; E Falck-Pedersen
Journal:  Mol Cell Biol       Date:  1994-07       Impact factor: 4.272

6.  A sequence downstream of AAUAAA is required for rabbit beta-globin mRNA 3'-end formation.

Authors:  A Gil; N J Proudfoot
Journal:  Nature       Date:  1984 Nov 29-Dec 5       Impact factor: 49.962

7.  Four factors are required for 3'-end cleavage of pre-mRNAs.

Authors:  Y Takagaki; L C Ryner; J L Manley
Journal:  Genes Dev       Date:  1989-11       Impact factor: 11.361

8.  Two proteins crosslinked to RNA containing the adenovirus L3 poly(A) site require the AAUAAA sequence for binding.

Authors:  C L Moore; J Chen; J Whoriskey
Journal:  EMBO J       Date:  1988-10       Impact factor: 11.598

9.  Alpha-thalassaemia caused by a poly(A) site mutation reveals that transcriptional termination is linked to 3' end processing in the human alpha 2 globin gene.

Authors:  E Whitelaw; N Proudfoot
Journal:  EMBO J       Date:  1986-11       Impact factor: 11.598

10.  Monoclonal antibody characterization of the C proteins of heterogeneous nuclear ribonucleoprotein complexes in vertebrate cells.

Authors:  Y D Choi; G Dreyfuss
Journal:  J Cell Biol       Date:  1984-12       Impact factor: 10.539

View more
  29 in total

1.  Analysis of a noncanonical poly(A) site reveals a tripartite mechanism for vertebrate poly(A) site recognition.

Authors:  Krishnan Venkataraman; Kirk M Brown; Gregory M Gilmartin
Journal:  Genes Dev       Date:  2005-06-01       Impact factor: 11.361

Review 2.  A systematic analysis of disease-associated variants in the 3' regulatory regions of human protein-coding genes II: the importance of mRNA secondary structure in assessing the functionality of 3' UTR variants.

Authors:  Jian-Min Chen; Claude Férec; David N Cooper
Journal:  Hum Genet       Date:  2006-06-29       Impact factor: 4.132

3.  Specific trans-acting proteins interact with auxiliary RNA polyadenylation elements in the COX-2 3'-UTR.

Authors:  Tyra Hall-Pogar; Songchun Liang; Lisa K Hague; Carol S Lutz
Journal:  RNA       Date:  2007-05-16       Impact factor: 4.942

4.  Splicing factors stimulate polyadenylation via USEs at non-canonical 3' end formation signals.

Authors:  Sven Danckwardt; Isabelle Kaufmann; Marc Gentzel; Konrad U Foerstner; Anne-Susan Gantzert; Niels H Gehring; Gabriele Neu-Yilik; Peer Bork; Walter Keller; Matthias Wilm; Matthias W Hentze; Andreas E Kulozik
Journal:  EMBO J       Date:  2007-04-26       Impact factor: 11.598

Review 5.  3' end mRNA processing: molecular mechanisms and implications for health and disease.

Authors:  Sven Danckwardt; Matthias W Hentze; Andreas E Kulozik
Journal:  EMBO J       Date:  2008-02-06       Impact factor: 11.598

Review 6.  Protein factors in pre-mRNA 3'-end processing.

Authors:  C R Mandel; Y Bai; L Tong
Journal:  Cell Mol Life Sci       Date:  2008-04       Impact factor: 9.261

7.  An RNA-protein complex links enhanced nuclear 3' processing with cytoplasmic mRNA stabilization.

Authors:  Xinjun Ji; Jian Kong; Stephen A Liebhaber
Journal:  EMBO J       Date:  2011-05-27       Impact factor: 11.598

Review 8.  Ending the message: poly(A) signals then and now.

Authors:  Nick J Proudfoot
Journal:  Genes Dev       Date:  2011-09-01       Impact factor: 11.361

9.  A physical and functional link between splicing factors promotes pre-mRNA 3' end processing.

Authors:  Stefania Millevoi; Adrien Decorsière; Clarisse Loulergue; Jason Iacovoni; Sandra Bernat; Michael Antoniou; Stéphan Vagner
Journal:  Nucleic Acids Res       Date:  2009-06-08       Impact factor: 16.971

Review 10.  Molecular mechanisms of eukaryotic pre-mRNA 3' end processing regulation.

Authors:  Stefania Millevoi; Stéphan Vagner
Journal:  Nucleic Acids Res       Date:  2009-12-30       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.